Catalyst Wire Dossier Catalyst Wire Dossier

LMB-2 immunotoxin

LMB-2 immunotoxin
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LMB-2 immunotoxin, covering 2012-03-16 to 2012-06-14. Get the full timeline:

Most recent: Clinical Trial Update: LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery [Phase 2]

See pricing